Cancer Home > Trastuzumab Drug Information

If you have been diagnosed with breast cancer or stomach cancer, your healthcare provider may recommend a drug called trastuzumab (Herceptin®). This product is part of a group of medications called monoclonal antibodies.
As a type of biologic therapy, trastuzumab is less "toxic" than chemotherapy. However, it is not suitable for everyone. In fact, this drug is only used to treat cancers that have a high concentration of HER2 receptors. (HER2 is a protein on the outside of certain cancer cells.)
The medication is given intravenously (through an IV). Depending on your dosing regimen, it is given every seven days or every three weeks, depending on certain factors.
(Click Trastuzumab for more information on this drug, including side effects and how it performed in clinical studies.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation




Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.